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Traditional mammalian expression systems rely on the time-consuming generation of stable cell lines;
this is difﬁcult to accommodate within a modern structural biology pipeline. Transient transfections
are a fast, cost-effective solution, but require skilled cell culture scientists, making man-power a limiting
factor in a setting where numerous samples are processed in parallel. Here we report a strategy employ-
ing a customised CompacT SelecT cell culture robot allowing the large-scale expression of multiple pro-
tein constructs in a transient format. Successful protocols have been designed for automated transient
transfection of human embryonic kidney (HEK) 293T and 293S GnTI cells in various ﬂask formats. Pro-
tein yields obtained by this method were similar to those produced manually, with the added beneﬁt of
reproducibility, regardless of user. Automation of cell maintenance and transient transfection allows the
expression of high quality recombinant protein in a completely sterile environment with limited support
from a cell culture scientist. The reduction in human input has the added beneﬁt of enabling continuous
cell maintenance and protein production, features of particular importance to structural biology labora-
tories, which typically use large quantities of pure recombinant proteins, and often require rapid charac-
terisation of a series of modiﬁed constructs. This automated method for large scale transient transfection
is now offered as a Europe-wide service via the P-cube initiative.
 2011 Elsevier Inc. Open access under CC BY license.1. Introduction
Fewer than 3% of the protein structures currently deposited in
the Protein Data Bank (PDB) were solved using samples produced
in mammalian cells (Nettleship et al., 2010), despite the recent
emergence of rapid and cost-effective transient expression meth-
ods (Aricescu et al., 2006; Durocher et al., 2002; Meissner et al.,
2001). However, the problems encountered for the large-scale
expression of many proteins of eukaryotic, especially human, ori-
gin have increasingly focused attention on mammalian cell-based
expression systems as a route for the production of targets that
prove challenging in heterologous prokaryotic and insect cell
expression hosts. In mammalian expression systems the protein,
or complex, can be expressed in its native cell type, under physio-
logical conditions, with numerous molecular systems working to-
gether for efﬁcient production and quality control. Unfortunately,
the large-scale expression of eukaryotic proteins in a stable and
soluble form is still a major bottleneck. This is due, in part, to the
time consuming process required to maintain and expand cells,
and to perform transient transfections. Automated mammalian cellnne Jones), radu@strubi.ox.
ipt.
 license.culture using stably transfected cell lines is becoming increasingly
prevalent in many stages of drug discovery (Szymanski et al.,
2008). In its current form however, time considerations mean that
it is of less use in modern structural biology laboratories, where
many different constructs are typically processed in parallel and
rapid feedback loops, supported by automated protein crystallisa-
tion (Walter et al., 2003, 2005), may necessitate construct re-de-
sign within a two week cycle (Aricescu et al., 2006). Manual cell
culture, typically performed by experienced staff, is highly repeti-
tive and requires considerable time commitment and is therefore
an ideal candidate for automation. Automated tissue culture using
the SelecT robot has already been reported for stable cell lines used
in drug discovery programmes, demonstrating advantages such as
consistency between operators and batches, ease of use and re-
duced risks of contamination (Szymanski et al., 2008). Robotic
transient transfection poses a signiﬁcant challenge for such exist-
ing cell culture systems however, largely due to the requirement
to exchange media and deliver various transfection mixtures to
ﬂasks in a linear sequence within a strict time frame.
We present here simple and reproducible protocols for the
automated large-scale transient transfection of constructs cloned
into the pHLsec vector (Aricescu et al., 2006) in two human cell
lines: HEK 293T and the N-glycosylation deﬁcient HEK 293S GnTI
(Reeves et al., 2002). A survey of 75 different protein batches, ex-
pressed using this robot over a four month period, allowed us to
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fulness of such a machine in the demanding environment of an
academic X-ray crystallography laboratory.2. Materials and methods
2.1. Vectors and cell lines
The vector chosen for development of an automated transfec-
tion protocol was pHLsec. This vector was built on the pLEXm
backbone (Aricescu et al., 2006) and contains: pBR322 origin of
replication giving the high copy number in Escherichia coli needed
to obtain the high amounts of plasmid DNA required for transient
transfection; ampicillin resistance; a cytomegalovirus enhancer;
chick b-actin promotor to give high levels of expression; the rabbit
b-globin intron to increase RNA production; and a poly-A signal to
increase RNA stability. Two cell lines were chosen for the develop-
ment of automated transient transfection protocols for glycosyl-
ated mammalian proteins: HEK 293T (ATCC CRL-11268), grown
in the presence of the N-glycosylation inhibitor, kifunensine
(Chang et al., 2007) added immediately post-transfection at
1 mg/L ﬁnal concentration, and the N-acetylglucosaminyltransfer-
ase I-negative HEK 293S GnTI cells (Reeves et al., 2002), which
are unable to synthesize complex glycans. These cell lines were
chosen due to ease of handling, robust growth rates, excellent
transfection efﬁciency, high capacity for recombinant protein
expression and low cost media requirements. Both cell lines are
also routinely used for manual transient transfections, thus allow-
ing a direct comparison between automated and manual protocols.
2.2. DNA puriﬁcation
The Endotoxin-Free Plasmid High Speed Giga Kit (Qiagen) was
used to purify plasmid DNA. High-quality DNA is essential for suc-
cessful transfections and only samples with an OD260/280 ratio of
1.8 or higher are suitable. The pLEXm-derived plasmids are very
high copy number, therefore one can expect between 12 and
15 mg of pure DNA from a 2 L overnight bacterial culture (E. coli
DH5a strain). It is essential that DNA samples are sterile, so care
was taken to wash the DNA precipitates with 70% ethanol before
dissolving them in sterile 10 mM Tris pH 8.
2.3. Transfection reagent
Polyethylenimine (PEI) is an affordable and highly efﬁcient
transfection reagent. The PEI used in both manual and automated
protocols is ‘25 kDa branched’ (Sigma–Aldrich), which was re-
ported to be effective in transfecting various HEK293 cell lines
(Aricescu et al., 2006; Durocher et al., 2002). Stock solutions were
made in water at 100 mg ml1, the pH adjusted to 7 with HCl, ﬁlter
sterilised and aliquoted. Aliquots and working solutions of
1 mg ml1 can be stored frozen at 20 C for long periods of time
(months) without a reduction in transfection efﬁciency.
2.4. Cell maintenance protocol
Cells were grown in Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM high glucose, Sigma) supplemented with L-glutamine,
non-essential amino-acids (Invitrogen) and 10% Foetal Bovine Ser-
um (FBS, Invitrogen). Cells were manually cultured from stocks
stored at 196 C, using a T25 ﬂask (Corning). On reaching 90%
conﬂuence, cells were detached using trypsin–EDTA (Sigma),
seeded in a T75 ﬂask (Corning or Greiner) and ﬁnally transferred
to a barcoded T175 ﬂask (Corning or BD-Falcon) and imported into
the CompacT SelecT Cellbase robot (The Automation Partnership,Royston, UK), where all subsequent cell maintenance was
automated.
2.5. Automated cell maintenance and seeding
Cells were harvested from 90% conﬂuent T175 ﬂasks, analysed
by the Cedex automated cell counter and diluted to a concentration
of 1.6  106 cells ml1 in DMEM, 10% FBS. New bar-coded T175
ﬂasks were then called from the CompacT SelecT Cellbase incuba-
tor hotel and seeded by pipetting 107 cells per ﬂask, supplemented
with DMEM, 10% FBS to a ﬁnal volume of 30 ml. The robotic Stäubli
arm then swirled the ﬂask to mix the cells before placing it in the
hotel incubator. Cells were passaged twice a week, using a trypsin–
EDTA mix (Sigma) for detachment, to a maximum of 20 passages
before new aliquots were retrieved from liquid nitrogen storage.
Triple ﬂasks (Nunc) were seeded with 2  107 cells, topped up to
110 ml with DMEM/10% FBS. Ten layer HYPERFlasks (High Yield
PERformance Flask, Corning) were seeded with 6  107 cells, and
topped up to 555 ml with DMEM, 10% FBS. Both ﬂask types were
returned to the robot incubator for four days, irrespective of the
cell line used, prior to transfection. We provide the protocol codes
for these procedures in Supplementary Figs. 1–3.
2.6. Automated transient transfection protocol
The transfection cocktail was prepared manually prior to the
automated transient transfection of Triple ﬂasks or HYPERFlasks.
To transfect 12 Triple ﬂasks, 1.8 mg plasmid DNA was chloroform
extracted (to ensure sample sterility) prior to addition of 360 ml
serum free DMEM. Mixing was followed by the addition of 3.6 ml
PEI stock (1 mg ml1) with brief swirling followed by a 10 min
incubation at room temperature to allow DNA-PEI complex forma-
tion. The robot can follow only linear protocols, as it has but one
arm. The automated protocol for Triple ﬂasks differed from that
used manually as the robot cannot work quickly enough to trans-
fect 12 Triple ﬂasks (a typical batch size, providing 1.2 L of condi-
tioned media) in less than the hour before transfection efﬁciency
begins to drop (see Section 3.1). To prevent this problem, it was
necessary to stack two programs: the ﬁrst program adds the trans-
fection cocktail to each of the 12 ﬂasks (30 ml per Triple ﬂask), and
when this procedure is completed for all the ﬂasks, a second pro-
gram is run to top up the ﬂasks to the ﬁnal volume of 100 ml with
DMEM, containing a ﬁnal FBS concentration of 1.6% (Supplemen-
tary Fig. 4). To transfect one HYPERFlask, chloroform extracted
DNA was added manually to 100 ml serum-free DMEM, mixed,
supplemented with 2 ml PEI stock (1 mg ml1) and brieﬂy mixed
by swirling followed by a 10 min incubation at room temperature
to allow DNA-PEI complex formation. Afterwards, the automated
transfection protocol was started. Flasks seeded four days prior
to transfection were taken from the incubator and media removed
by pouring into the waste receptacle. The DNA:PEI complexes were
then added to the ﬂasks (100 ml per HYPERFlask), followed by low
serum DMEM (455 ml per HYPERFlask), resulting in a ﬁnal FBS
concentration of 1.6%.
2.7. Manual transfection in roller bottles
This was typically performed as described in Aricescu et al.
(2006). Half a milligram of plasmid DNA was used for transfection
in each 2125 cm2 expanded surface roller bottle (Greiner). Brieﬂy,
the DNA solution was added to 50 ml serum-free DMEM, mixed,
supplemented with 1 ml PEI stock (1 mg ml1) and vortexed for
10 s. This solution was incubated for 10 min at room temperature
to allow DNA–PEI complex formation. During complex formation,
media from the roller bottles was changed, lowering the serum
concentration (200 ml of DMEM, 2% FBS, were added per roller
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brieﬂy rotated to allow mixing, after which the cells were placed
in the incubator. Approximately 4–7 days later, conditioned med-
ium was ready for collection and protein puriﬁcation.2.8. Fluorescence microscopy
Imaging of transfection efﬁciency using EGFP-pLEXm constructs
was carried out with a Nikon Eclipse TE2000U ﬂuorescence in-
verted microscope equipped with a Hamamatsu C4742-95 Orca
low-noise B&W CCD and using IPLab imaging software to capture
and process images.2.9. Western blot analysis
Small aliquots of conditioned media (10 ll) were analysed by
Western blotting using the PentaHis monoclonal antibody
(1:1000 dilution, Qiagen) and goat anti-mouse IgG peroxidase-
conjugated secondary antibody (diluted 1:2000, Sigma). The signal
was visualised by chemiluminescence using the ECL kit and hyper-
ﬁlm (GE Healthcare).2.10. Shh protein puriﬁcation
For the comparison between large-scale automated and manual
transfection procedures secreted His-tagged constructs of the N-
terminal domain of mouse sonic hedgehog (Shh) were puriﬁed
using an immobilised metal afﬁnity chromatography (IMAC) batch
procedure. Conditioned media were ﬁltered through a 0.2 lm
membrane (Express ﬁlter, Millipore) and dialysed against 25 mM
phosphate buffer saline (PBS, pH8.0) at 4 C to prevent metal strip-
ping from the afﬁnity chromatography column. IMAC puriﬁcation
was performed using cobalt-coated Talon beads (Clontech) which
were washed with 7.5 mM imidazole in PBS (pH 8.0), and proteins
eluted by addition of 250 mM Imidazole in 10 mM Tris, pH 8.0,
500 mM NaCl. The proteins were further puriﬁed by size exclusion
chromatography on a Superdex200 10/30 (GE Healthcare) column.3. Results
3.1. Automated transient transfection: protocol design,
implementation, optimisation
The CompacT SelecT robot (Fig. 1a–g), recently developed by
The Automation Partnership (Royston, Cambridge, UK), is a smaller
version of the SelecT automated cell culture platform. This system
retains more than 70% of the SelecT capacity and, importantly, is
able to manipulate 10 layer HYPERFlasks. Typically it is used for
cell-based drug screening or protein production using stable cell
lines (Szymanski et al., 2008). The CompacT Cellbase, a CompacT
SelecT without a plating module, was chosen for our mammalian
protein expression. The system consists of two compartments.
The ﬁrst is a humidiﬁed 5% CO2, 37 C carousel incubator/ﬂask
hotel unit (Fig. 1b) with space for 40 new input ﬂasks and 90
production ﬂasks for cell maintenance and transfection. The second
is a laminar ﬂow compartment containing a Stäubli robotic arm
(Stäubli Robotics, Faverges, France) (Fig. 1c), a pipette head
(Fig. 1d), a waste receptacle and ‘‘cocktail bar’’ (Fig. 1e). The laminar
ﬂow compartment also has a barcode reader to track ﬂasks and
a ﬂask de-capper (Fig. 1f). The unit also incorporates a Cedex
automated cell counting module (Fig. 1g). Cells are automatically
maintained by regular harvesting and seeding of T175 ﬂasks,
while production is performed in Triple ﬂasks and HYPERFlasks,
following the ﬂowchart described in Fig. 1h.We designed and extensively tested a series of protocols for
routine cell maintenance as well as transfection in various ﬂask
formats (protocol codes and schematic diagrams are shown in Sup-
plementary online materials). To establish the optimal transfection
protocol for Triple ﬂasks and HYPERFlasks, a pLEXm vector encod-
ing the EGFP was used to allow visualisation and quantiﬁcation of
cell transfection efﬁciency. A series of time points after addition of
PEI to DNA was investigated, in order to determine the maximum
number of efﬁcient transfections achievable with one batch of
DNA:PEI mix. Optimal transfection was achieved when adherent
cells reached 90% conﬂuence. DNA requirements were 150 lg per
Triple ﬂask and 1 mg per HYPERFlask. To determine the optimal
number of ﬂasks which could be efﬁciently transfected with one
batch of DNA:PEI mix, a range of incubation times was investi-
gated. Transfection efﬁciency, determined by monitoring live-cell
EGFP ﬂuorescence, remained stable for one hour after mixing PEI
with DNA, but subsequently started to decrease (Fig. 2a). Each
HYPERFlask takes eight minutes to complete the transfection pro-
tocol, therefore no more than six HYPERFlasks can be transfected
from one batch of DNA-PEI mixture if efﬁciency is to be
maintained.
The reliability of the whole procedure was tested by using this
system to seed and independently transfect (during the same day)
24 different T175 ﬂasks with the same pHLsec construct, encoding
a 50 kDa glycoprotein. A sample of media from each ﬂask was col-
lected and analysed by western blot with an anti-His tag antibody,
showing consistent protein expression (Fig. 2b) when compared to
the two orders of magnitude variation which, in our experience,
can arise from human error.3.2. Comparison between large-scale automated and manual
transfection procedures
It was important to ensure that the efﬁciency of protein pro-
duction resulting from the automated transfection protocol
matched that of the manual system in order to demonstrate that
automated transient transfection was a viable alternative. To this
end, test expression experiments using the N-terminal signalling
domain of mouse sonic hedgehog (Shh), solubly secreted in the
conditioned medium (Bishop et al., 2009), were performed in
three conﬁgurations: four roller bottles manually transfected with
2 mg DNA; automated transfection of 12 Triple ﬂasks with 1.8 mg
DNA; and automated transfection of two HYPERFlasks with 2 mg
DNA. Four days post transfection, media were harvested and puri-
ﬁed before analysing the protein samples by SEC and SDS–PAGE
(Fig. 3a–c). The construct was well expressed in all procedures
(Fig. 3d), demonstrating that the robot is a viable alternative to
manual tissue culture. The smaller footprint of HYPERFlasks pro-
vides an advantage over the Triple variant, occupying fewer slots
in the incubator hotel for a comparable output. However, the pro-
tein produced is at roughly half the concentration of that ob-
served for roller bottles. In terms of real ‘‘hands-on’’ time, the
beneﬁt of automation is directly proportional to the scale of the
experiment. A typical experiment of manual transfection in 12
roller bottles takes approximately 30 min of operator input, sim-
ilar to automated transfection of six HYPERFlasks (giving an
equivalent volume of media). Doubling the output on the robot
adds 10 further minutes of operator time, signiﬁcantly less than
doubling the number of roller bottles handled manually, which
typically takes a lot longer due to operator fatigue. The greatest
beneﬁt of automation results from cell maintenance and seeding
procedures, which require minimal operator input. Media and
ﬂasks must be supplied by an operator, but all subsequent proce-
dures can then be fully automated, running overnight if
necessary.
Fig.1. The different CompacT Cellbase robot modules, employed for cell maintenance, seeding and transfection. (a) The two robot units: incubator/hotel on the left, accessible
to the operator; laminar ﬂow cabinet for ﬂask processing, on the right. The robot arm can access the cell ﬂasks within the incubator carousel through an automated internal
door which is synchronised with carousel turning. All liquid cell culture reagents, such as media, PBS and trypsin are connected to the system through silicon tubing and
driven via peristaltic pumps. There are 10 pumps for up to 10 lines of different cell culture liquids. The robot system also coordinates the capping or decapping of ﬂasks and
presents the ﬂask to the relevant media line, delivering precise amounts of liquid. The system uses 10 ml pipettes for transferring cell suspensions or adding solutions from
the static liquid holder. (b) Carousel consisting of nine vertical hotels, each with a ten ﬂask capacity, for cell maintenance and four hotels with ten positions for new ﬂasks. (c)
The Stäubli robot arm gripping a single ﬂask, ready to be returned to the carousel incubator. (d) Splitting ﬂasks using the pipette head to transfer cells. (e) Pouring media from
a ﬂask into the waste receptacle. (f) The robot arm performing the ‘‘hyperswirl’’ command after transfection; the ‘‘cocktail bar’’ can also be seen on the left of the photo. (g)
The Cedex cell-counting module. (h) Workﬂow of automated cell culture, including cell maintenance, transfection and protein production steps. The only step performed
manually is the DNA:PEI mix preparation.
Fig.2. Optimisation of the transient transfection protocol and reliability tests. (a) Cells transfected by the robot at different time points after PEI:DNA mixing. Expression of
EGFP allowed visualisation of transfection efﬁciency following different incubation periods. Transfection protocols were designed to cater for this decrease in efﬁciency over
time. (b) Western blot analysis of samples from 24 separate T175 ﬂasks after automated transfection with the pHLsec vector encoding the same 50 kDa glycoprotein
construct.
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Data from HYPERFlask transient transfections performed on the
CompacT SelecT Cellbase robot over a period of four months, using
both HEK 293T and HEK 293S GnTI cells and using only constructsconﬁrmed to be secreted in small-scale experiments, revealed a
broad range of pure, crystallisation grade, protein yields (Fig. 4).
It should be noted that constructs showing low expression in small
scale tests were often put forward for automated transfection as
the yields from manual protocols had been found to be typically
Fig.3. Comparison of three protein expression strategies. The secreted form of the
mouse Shh N-terminal domain was puriﬁed from conditioned media by IMAC and
SEC (blue traces) and analysed by SDS–PAGE (inset) of peak fractions (shown by a
red bar on SEC traces). The protein was produced using: (a) four Roller bottles
seeded and transfected manually, (b) 12 Triple ﬂasks seeded and transfected by the
robot and (c) two HYPERFlasks, seeded and transfected by the robot. (d)
Table summarising the experimental output of the above experiment.
Fig.4. Pure protein yields obtained from HYPERFlasks during a four-month
automated production run in STRUBI. (a) 42 samples produced in HEK 293T cells
and (b) 33 samples produced in HEK 293S GnTI cells. Each sample represents an
individual construct which was transfected in a minimum of two and maximum of
twelve HYPERFlasks.
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different skill levels, handling 75 different samples of varied
molecular weight, number of N-linked glycosylation sites, fold
and number of domains and oligomeric state. An overall trend of
higher expression levels in HEK 293T (Fig. 4a) versus HEK 293S
GnTI cells (Fig. 4b) was observed, but in all cases the protein
quantities obtained were sufﬁcient to perform extensive crystalli-
sation trials using nanolitre scale technologies (Walter et al.,
2003, 2005). The inherent abilities of the two cell lines to produce
recombinant proteins may be responsible for the observed differ-
ences, however other factors such as the addition of kifunensine,
an a-mannosidase inhibitor used to reduce the complexity of N-
linked glycosylation (Chang et al., 2007), which inhibits ER-associ-
ated degradation (Tokunaga et al., 2003) cannot be excluded.4. Discussion
The automated protocols described here are equivalent to their
manual counterparts in terms of the quality and quantity of se-
creted mammalian proteins produced. The initial investment in
equipment, in the order of £500,000, and the 20% higher consum-
ables cost should be considered in balance with a 3-fold increase
in output above the physical ability of one experienced tissue
culture operator. In addition to reproducibility and robustness of
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provide a signiﬁcant beneﬁt in long term. From October 2009 to
November 2010, automated transfection protocols were responsi-
ble for the production of300 protein batches in our laboratory. Se-
creted proteins produced ranged in size from 10–200 kDa (Coles
et al., 2011; Janssen et al., 2010; Malinauskas et al., in press; Seira-
dake et al., 2010). Separate to the statistics presented (Fig. 4) we
have also succeeded in producing intracellular and membrane pro-
teins using the automated large scale transient expression system,
however, our experience for these classes of proteins is as yet more
limited.What are the beneﬁts of the automated protocols compared
to manual methods? The most obvious is the increased capacity for
cell culture and protein productionwhich becomes available, whilst
human effort is released for other tasks. The manual system is en-
tirely dependent on the skills and presence of an experienced cell
culture scientist. In the automated system, there is no such con-
straint and the vicissitudes of human error are also reduced. As long
as media reservoirs are ﬁlled as needed and ﬂasks loaded into the
robot, automated cell culture can continue 24 h a day 7 days a week
without break. Transient transfections, however, still require the
presence of an operator to prepare the cocktail of reagents and thus
can only be completed during normal working hours. With efﬁcient
time-tabling, all fully automated procedures can be completed out
of normal working hours and the machine monitored and operated
remotely via an internet based video link and control software if re-
quired. A further advantage over the manual roller bottle system is
that due to the low volume of media required in the roller bottles,
HEK 293T cells in the presence of kifunensine typically survive for
only 4 days post transfection while in HYPERFlasks efﬁcient gas ex-
change, allowed by the permeable membrane on which the cells
grow, results in cells producing proteins for up to 10 days post-
transfection. For HEK 293S GnTI efﬁcient expression time is in-
creased from a maximum of 7 days post-transfection in roller bot-
tles, to 14 days post-transfection in HYPERFlasks. This increased
production time may result in increased yields, however, this
advantage is counterbalanced by the increased risks of protein deg-
radation due to storage at 37 C and proteolysis, thus in general
users allowed the same maximum times for the expression of their
protein for HYPERFlasks as they did for roller bottles.
Automation of the manual mammalian expression protocol,
based on the pLEXm vectors (Aricescu et al., 2006), required some
modiﬁcation to allow for the limitations of the robot. Flasks of suit-
able geometry include T175 (for maintenance) and either Triple
ﬂasks or HYPERFlasks for transient production. Both offer the same
ease of handling for the robot, but the Triple ﬂasks occupy three
times more volume in the incubator for the equivalent surface area
of cell growth. Both types of ﬂask use a lot more media than
the roller bottles used in manual transfections. Roller bottles
require 250 ml culture media for a surface area of 2125 cm2
while Triple ﬂasks minimally require 100 ml each for a surface area
of 500 cm2 and HYPERFlasks require 555 ml for a surface area of
1720 cm2. This then requires a modiﬁcation of the amount of
DNA and PEI used in the transfection cocktail to ensure the correct
concentration of both in larger volumes. For roller bottles 0.5 mg
DNA with 1 ml PEI was required per bottle. For Triple ﬂasks,
150 lg DNA is required per ﬂask with 250 ll PEI, while for HYPER-
Flasks, 1 mg DNA per ﬂask with 2 ml PEI. Transfections are carried
out in the automated system using peristaltic pump delivery rather
than pipettes, as the robot is only able to handle 10 ml pipettes, not
a viable option for large volume transfers required by multi-lay-
ered ﬂasks. A major drawback of the HYPERFlasks is that they must
have 555 ± 1 ml in order to function properly. This requires daily
calibration of the pumps, which is not time consuming (less than
10 min) but cannot currently be performed remotely. The T175
and Triple ﬂasks do not require such rigorous calibration; a weekly
procedure offers sufﬁcient accuracy.Having used the CompacT SelecT Cellbase for more than a
year, many opportunities for improvements in both the hardware
and software have come to light. In terms of hardware, a more
consistent delivery system for media would be useful, which
would relax the requirement for daily calibration. It is currently
necessary to wash the peristaltic pump lines between transfection
constructs in order to prevent cross-contamination, a signiﬁcant
problem when the number of ﬂasks transfected with a given con-
struct is small (one or two). Allowing volumes greater than 40 ml
into the static liquid holder, located inside the laminar ﬂow unit,
would offer greater ﬂexibility in protocol design. Another issue
during full time production is the limited space available in the
robot incubator. All transfected ﬂasks are routinely removed to
free spaces in the nine incubator hotels (which can hold 90 ﬂasks
for production and cell maintenance, plus 40 new input ﬂasks at a
time). Without the use of additional incubators space would be
an issue and, in addition to downstream processing ability, would
be a limiting factor in protein production. The robot is currently
used to transfect up to 12 HYPERFlasks a day, and to maintain
the cells necessary for continuously operating this production cy-
cle. This is close to the maximum efﬁciency compatible with one
operator working normal hours. Finally, in terms of software, the
robot is currently unable to use incubation periods to complete
other tasks, for example cell passaging. However, even given
the current limitations, the automation of large scale transient
protein expression in mammalian cells has already had an im-
mensely positive impact on our ability to tackle structural and
function studies of challenging biological systems (for example
Janssen et al., 2010; Coles et al., 2011). Alternative solutions for
automation of small-scale expression and suspension cell culture
are available on the market, but remain to be tested in our labo-
ratory (Nettleship et al., 2010).5. Conclusions
The protocols described here are, to our knowledge, the ﬁrst
implementation of an automated tissue culture system for large
scale transient expression of secreted recombinant proteins in
mammalian cells in a quantity and of a quality suitable for X-ray
crystallography. Although somewhat more expensive than manual
systems in terms of consumables and requiring signiﬁcant initial
set-up cost, the time saved and the increased productivity makes
up for this initial investment. A major advantage of the automated
system is the reproducibility of expression between users and at
different times as well as the avoidance of simple human error. Fi-
nally, the automated protein production system described here is
available to all European users as part of the Protein Production
Platform (P-cube) (http://www.p-cube.eu/).Acknowledgments
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